Literature DB >> 2564857

Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.

D A Hafler1, M Chofflon, D Benjamin, N H Dang, J Breitmeyer.   

Abstract

The Ta1 (CDw26) Ag distinguishes a subset of circulating T lymphocytes that is the major population proliferating to recall Ag challenge. Unlike receptors for growth factors such as IL-2 and transferrin, the Ta1 Ag is present on T cell lines and clones irrespective of cell cycle. The appearance of Ta1 on T cells that respond to recall Ag allowed us to investigate activation requirements that may be associated with T cell immune memory. Ta1+ peripheral blood T cells were induced to proliferate by mAb recognizing either the invariant chains of the TCR, or by pairs of mitogenic antibodies directed to the CD2 molecule. In contrast, Ta1- cells were not stimulated by these antibodies. In addition, Ta1-cells did not proliferate maximally after addition of the phorbol ester PMA in combination with the calcium ionophore Ionomycin, suggesting that the intracellular targets of these agents may not be fully active. Anti-CD3-induced elevation of intracellular calcium levels was equivalent in the two subpopulations, suggesting that calcium mobilization mechanisms were intact. In contrast, PMA-induced phosphorylation of TCR CD3 chains was significantly greater in Ta1+ cells as compared to Ta1- T cells. Taken together, our results indicate that Ta1 expression, which is associated with T cell activation and memory, may be causally related to TCR and CD2-mediated activation mechanisms. The PMA inducible TCR phosphorylation in Ta1+ memory cells associated with their increased ability to proliferate after CD3/TCR or CD2 stimulation suggests that intracellular phosphorylation events may be causally associated with T cell immune memory.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564857

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

Authors:  W G Gutheil; M Subramanyam; G R Flentke; D G Sanford; E Munoz; B T Huber; W W Bachovchin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

2.  Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups.

Authors:  F W Miller; L A Love; S A Barbieri; J E Balow; P H Plotz
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Authors:  T Tanaka; J Kameoka; A Yaron; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

4.  CD26 induces T-cell proliferation by tyrosine protein phosphorylation.

Authors:  E Muñoz; M V Blazquez; J A Madueño; G Rubio; J Peña
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

Review 5.  DPPIV/CD26: a tumor suppressor or a marker of malignancy?

Authors:  Aline Beckenkamp; Samuel Davies; Júlia Biz Willig; Andréia Buffon
Journal:  Tumour Biol       Date:  2016-03-04

6.  Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection.

Authors:  Chris C Ibegbu; Yong-Xian Xu; Dimitri Fillos; Henry Radziewicz; Arash Grakoui; Athena P Kourtis
Journal:  Immunology       Date:  2008-07-22       Impact factor: 7.397

7.  Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients.

Authors:  C Muscat; A Bertotto; E Agea; O Bistoni; R Ercolani; R Tognellini; F Spinozzi; M Cesarotti; R Gerli
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

8.  Activation of lymphocytes after platelet allotransfusion possessing only class I MHC product.

Authors:  E Pócsik; R Mihalik; E Gyódi; M Réti; K Pálóczi; G G Petrányi; M Benczúr
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

9.  Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies.

Authors:  J L De Bleecker; A G Engel
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.